2021 Annual Meeting Foot & Ankle Access Pass-Osteochondral Autograft Transplantation with Micronized Allograft Cartilage Matrix Augmentation

Osteochondral Autograft Transplantation with Micronized Allograft Cartilage Matrix Augmentation

Video Transcription

Video Summary

A study at NYU Langone compared treating osteochondral lesions of the talus (OLT) using autologous osteochondral transplantation (AOT) combined with concentrated bone marrow aspirate (CBMA), with or without augmentation by EMCA (a biocartilage product). Reviewing 60 patients retrospectively, mostly with uncontained lesions, both groups showed significant functional improvement, with no significant difference in MRI (MoCART) scores or outcomes. Complication rates were slightly higher in the EMCA group. The study concluded that while AOT-CBMA is effective for OLT, adding EMCA may help with irregular lesions but does not significantly outperform CBMA alone.

Asset Caption

Dr. Alan Samsonov

Keywords

osteochondral lesions of the talus

autologous osteochondral transplantation

concentrated bone marrow aspirate

EMCA biocartilage

functional outcomes in OLT treatment